Non-steroidal Anti-inflammatory Drug Use and Risk of Age-Related Macular Degeneration in the California Teachers Study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Brown GC, Brown MM, Sharma S, Stein JD, Roth Z, Campanella J, et al. The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc. 2005;103:173.
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379(9827):1728–38.
Velez-Montoya R, Oliver SCN, Olson JL, Fine SL, Quiroz-Mercado H, Mandava N. Current knowledge and trends in age-related macular degeneration: genetics, epidemiology, and prevention. Retina. 2014;34(3):423–41.
Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134(3):411–31.
Maloney SC, Fernandes BF, Castiglione E, Antecka E, Martins C, Marshall J-C, et al. Expression of cyclooxygenase-2 in choroidal neovascular membranes from age-related macular degeneration patients. Retina. 2009;29(2):176–80.
Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf. 2002;11(8):687–93.
Carney RM, Freedland KE, Eisen SA, Rich MW, Skala JA, Jaffe AS. Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav Med. 1998;24(1):35–9.
O’Connor PJ, Pronk NP, Tan AW, Rush WA, Gray RJ. Does professional advice influence aspirin use to prevent heart disease in an HMO population. Eff Clin Pract. 1998;1(1):26–32.
Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among US adults: behavioral risk factor surveillance system. Am J Prev Med. 2006;30(1):74–7.
Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10(1):31.
Liew G, Mitchell P, Wong TY, Rochtchina E, Wang JJ. The association of aspirin use with age-related macular degeneration. JAMA Intern Med. 2013;173(4):258–64.
Klein BEK, Howard KP, Gangnon RE, Dreyer JO, Lee KE, Klein R. Long-term use of aspirin and age-related macular degeneration. JAMA. 2012;308(23):2469–78.
de Jong PTVM, Chakravarthy U, Rahu M, Seland J, Soubrane G, Topouzis F, et al. Associations between aspirin use and aging macula disorder: the European Eye Study. Ophthalmology. 2012;119(1):112–8.
Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, et al. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Arch Ophthalmol. 2001;119(8):1143–9.
Christen WG, Glynn RJ, Chew EY, Buring JE. Low-dose aspirin and medical record–confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology. 2009;116(12):2386–92.
Swanson MW, McGwin G Jr. Anti-inflammatory drug use and age-related macular degeneration. Optom Vis Sci. 2008;85(10):947–50.
Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, et al. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control. 2002;13(7):625–35.
Duan L, Xu X, Koebnick C, Lacey JV, Sullivan-Halley J, Templeman C, et al. Bilateral oophorectomy is not associated with increased mortality: the California Teachers Study. Fertil Steril. 2012;97(1):111–7.
Xu X, Ritz B, Coleman A, Liew Z, Deapen D, Lee E et al. Hypertension, antihypertensive medications use and risk of age-related macular degeneration in California Teachers Cohort. J Human Hypertens. 2020;34(8):568–76.
Foley SM, Daley J, Hughes J, Fisher ES, Heeren T. Comorbidities, complications, and coding bias: does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA. 1992;267(16):2197–203.
Halpern MT, Schmier JK, Covert D, Venkataraman K. Resource utilization and costs of age-related macular degeneration. Health Care Financ Rev. 2006;27(3):37.
Age-Related Eye Disease Study Research G. Risk factors associated with age-related macular degeneration: a case–control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology. 2000;107(12):2224–32.
Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst. 2005;97(11):805–12.
Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6):656–64.
Zell JA, Ziogas A, Bernstein L, Clarke CA, Deapen D, Largent JA, et al. Nonsteroidal anti-inflammatory drugs. Cancer. 2009;115(24):5662–71.
Keenan TDL, Goldacre R, Goldacre MJ. Associations between age-related macular degeneration, osteoarthritis and rheumatoid arthritis: record linkage study. Retina. 2015;35(12):2613–8.
Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN, et al. Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med. 2006;12(3):330–4.
Ridker PM, Manson JE, Buring JE, Goldhaber SZ, Hennekens CH. The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians’ Health Study. Am Heart J. 1991;122(6):1588–92.
Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PTVM. Age-related macular degeneration is associated with atherosclerosis the Rotterdam Study. Am J Epidemiol. 1995;142(4):404–9.
Nowak JZ. Aspirin and age-related macular degeneration: positives versus negatives. Routledge: Taylor & Francis; 2014.
Zhu W, Wu Y, Xu D, Li Y-H, Jun B, Zhang X-L, et al. Aspirin use and risk of age-related macular degeneration: a meta-analysis. PLoS ONE. 2013;8(3):58821.
Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation. 2002;106(3):388–91.
Michet Iii CJ, Achenbach SJ, Crowson CS, Matteson EL. Hospitalization rates and utilization among patients with giant cell arteritis: a population-based study from 1987 to 2012. Amsterdam: Elsevier; 2015.
Wang JJ, Mitchell P, Smith W, Gillies M, Billson F. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2003;10(1):37–48.
Klein R, Klein BK, Jensen SC, et al. Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol. 2001;119(9):1354–9. https://doi.org/10.1001/archopht.119.9.1354.
Ayalasomayajula SP, Kompella UB. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. Eur J Pharmacol. 2003;458(3):283–9.
Age-Related Eye Disease Study Research G. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19. Ophthalmology. 2005;112(4):533–9.
Robman L, Guymer R, Woods R, Ward S, Wolfe R, Phung J, et al. Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: rationale and study design of the ASPREE-AMD study. Contemp Clin Trials Commun. 2017;6:105–14.
Kahawita SK, Casson RJ. Aspirin use and early age-related macular degeneration: a meta-analysis. Can J Ophthalmol J Can d’Ophtalmol. 2014;49(1):35–9.
Ying G-S, Maguire MG, Daniel E, Grunwald JE, Ahmed O, Martin DF, et al. Association between antiplatelet or anticoagulant drugs and retinal or subretinal hemorrhage in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2016;123(2):352–60.